top of page
Scientist with Test Tubes_edited_edited.jpg

EFIL turns LIFE around

Revolutionizing Metabolic and Related Disease Treatments

Our Current Focus

EFIL targets metabolic diseases with innovative ACAT inhibitor treatments where traditional therapies fall short.hort.

EFIL BioScience Inc.

 

Suite 602, Bando Ivyvalley, 686 Cheonggyesan-ro, Soojeong-gu, Seongnam, Gyeonggi-do, Republic of Korea 13105 

Email: media@efilbio.com

​

Copyright ⓒ 2021-2025 EFIL BioScience Inc. All rights Reserved.

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
bottom of page